Sandy Health Centre

01767 682525

Health Visitors/District Nurses

01767 224100

Syringe driver pumps: T34™ 3rd edition models only – stop using the pump until updated instructions for use and BodyCommTM V3.0 software are released (MDA/2019/038)

Manufactured by CME (a BD company) – the intended operation of these pumps cannot be verified due to errors in the instructions for use (IFUs) and the incompatibility with older … [continue] Syringe driver pumps: T34™ 3rd edition models only – stop using the pump until updated instructions for use and BodyCommTM V3.0 software are released (MDA/2019/038)

Field Safety Notice: 21 October to 25 October

List of field safety notices (FSNs) from medical device manufacturers from 21 October to 25 October https://www.gov.uk/drug-device-alerts/field-safety-notice-21-october-to-25-october?utm_source=2c976583-23cc-4366-af95-2675aed473ab&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate  

Field Safety Notice: 14 October to 18 October

List of field safety notices (FSNs) from medical device manufacturers from 14 October to 18 October https://www.gov.uk/drug-device-alerts/field-safety-notice-14-october-to-18-october?utm_source=f5b450c1-4d08-42ef-9ee9-1c54ab18a4ac&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate

Class 4 Medicines Defect Information: Xonvea 10 mg/10 mg gastro-resistant tablets (MDR 025-10/19)

Alliance Pharmaceuticals Ltd has informed the MHRA that there are possible side effects not reported on the Patient Information Leaflet. https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-xonvea-10-mg-10-mg-gastro-resistant-tablets-mdr-025-10-19?utm_source=53c4589f-da0d-47d2-b9d3-656a6f32b705&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate

Class 2 Medicines recall: Ranitidine Effervescent Tablets 150mg, Ranitidine Effervescent Tablets 300mg (EL (19)A/27)

Teva UK Limited trading as ratiopharm GmbH is recalling all unexpired stock of Ranitidine Effervescent Tablets from pharmacies. https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-ranitidine-effervescent-tablets-150mg-ranitidine-effervescent-tablets-300mg-el-19-a-27?utm_source=dc70e3f3-ae6c-4e83-a18f-d928dc113d08&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate

Field Safety Notice: 7 October to 11 October

List of field safety notices (FSNs) from medical device manufacturers from 7 October to 11 October https://www.gov.uk/drug-device-alerts/field-safety-notice-7-october-to-11-october?utm_source=50cac182-8e26-4df7-b846-25b768ed555b&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate

Field Safety Notice: 30 September to 04 October

List of field safety notices (FSNs) from medical device manufacturers from 30 September to 04 October https://www.gov.uk/drug-device-alerts/field-safety-notice-30-september-to-04-october?utm_source=d1462174-e2d9-49c2-bb59-17f8e7668787&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate

Class 4 Medicines Defect Information: Emerade 150, 300 and 500 microgram solution for injection in pre-filled syringe (MDR 57-08/19)

The MHRA has notified Bausch and Lomb UK Limited of reports that Emerade pens have failed to activate. The MHRA is advising that Emerade devices should not be recalled. https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-emerade-150-300-and-500-microgram-solution-for-injection-in-pre-filled-syringe-mdr-57-08-19?utm_source=f03b2ee9-32c9-4c29-9dde-a224560325d3&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate

Field Safety Notice: 23 to 27 September

List of field safety notices (FSNs) from medical device manufacturers from 23 to 27 September 2019. https://www.gov.uk/drug-device-alerts/field-safety-notice-23-to-27-september?utm_source=14239d94-3094-4ccc-8409-8b9756e1335c&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate

Translate »